Breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot

Breast cancer, the second most common cancer in the United States, can result from a number of cellular misregulations, such as deficiencies in the DNA-repairing breast cancer gene, BRCA. Typically, BRCA-associated breast cancer is treated with poly ADP ribose polymerase (PARP) inhibitors and, recently, clinical trials have investigated pairing PARP inhibitor therapy with immunotherapy. Based…

Details

AOAC INTERNATIONAL certifies three test kits for detecting novel coronavirus on surfaces

AOAC INTERNATIONAL announced today that it has issued Certificates of Validation for three proprietary test kits that detect SARS-CoV-2, the causative agent of COVID-19 illness, on environmental surfaces. The three tests are the first to pass the rigorous independent evaluation required by the globally recognized AOAC Research Institute‘s Performance Tested MethodsSM Program, which implemented an…

Details